cardiovascular outcomes glp-1 news today disease continuum-GLP-1 action. Adapted from [46] Glucagon-like peptide 1 receptor agonists:

Should You Stop Taking GLP-1 Injections Because of Hair Loss

Coqueiro AY, Rogero MM, Tirapegui J

Phase 2 Side-Effect Frequencies at 4.5 mg/week (Lancet 2021) Side Effect Nausea Incidence at 4.5 mg/week 47% Side Effect Injection-site reactions Incidence at 4.5 mg/week 43% Side Effect Constipation Incidence at 4.5 mg/week 21% Side Effect Fatigue Incidence at 4.5 mg/week 20% Side Effect Allergic reactions (any) Incidence at 4.5 mg/week 10% Side Effect Vomiting Incidence at 4.5 mg/week 8% Side Effect Loose stools Incidence at 4.5 mg/week 7% Side Effect Headache Incidence at 4.5 mg/week 7% Side Effect Indigestion Incidence at 4.5 mg/week 4% Incidence was lower at lower doses

Ongoing Support We schedule regular follow-up appointments to monitor your progress, make necessary adjustments, and provide motivation

Once your online health assessment is reviewed by a licensed clinician, your prescription is issued and sent to the pharmacy the same day in most cases Willow offers both injectable and oral GLP-1 options making it the strongest choice for patients who want to avoid weekly injections entirely